It’s Time to REACT: New Literature on Antiplatelet Agents and Anticoagulants for the Treatment and Prevention of Acute Coronary Syndrome

Rochester, NY US
March 25, 2020

This presentation will present all of the head-to-head clinical trials conducted on antiplatelet agents in the setting of acute coronary syndrome. After presenting the ISAR-REACT trial, pharmacists will understand why prasugrel is the preferred agent in select populations based on the methods and outcomes of this trial. We will close the knowledge gap pertaining to anticoagulants in the setting of ACS and how to address triple therapy by discussing the current ACC/AHA guidelines as well as discuss the most recent literature published about discontinuing antiplatelet therapy in our patients who have stable ischemic heart disease. The presentation will include a discussion on the potential role of anticoagulants for the secondary prevention of acute coronary syndrome outside of patients with atrial fibrillation.

Target Audience

  • Pharmacists

Learning Objectives

  1. List the current treatment options for the treatment of acute coronary syndrome
  2. Compare and contrast available antiplatelet agents for the acute treatment of acute coronary syndrome
  3. Define the role of triple therapy for patients with acute coronary syndrome
  4. Describe the role of direct oral anticoagulants for the secondary prevention of acute coronary syndrome

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
03/25/2020
Course expires: 
05/10/2020
Event starts: 
03/25/2020 - 7:00am
Event ends: 
03/25/2020 - 8:00am
Cost:
$0.00
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY 14642
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
The presenter will discuss off-label use of drugs
 
Planning committee members
Linda Thomas, PharmD, BCPS
Pharmacy Residency Coordinator
University of Rochester Medical Center
 
Jennifer Falvey, PharmD, BCPS
Cardiovascular Clinical Pharmacy Specialist
University of Rochester Medical Center
 
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
 
Presenter
Mikaela R. Brown, PharmD
PGY-1 Pharmacy Resident
University of Rochester Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
___________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-004-L01-P
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.